|
Model Number 04V5121 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/30/2022 |
Event Type
malfunction
|
Event Description
|
The customer observed falsely elevated alinity c total bilirubin results for eight patients generated on the alinity c analyzer.The samples were repeated on the roche analyzer which generated normal results.The customer then ran controls on the alinity c analyzer, and the controls were also out of range high.The customer performed daily maintenance, repeated the controls and controls were back in range.The customer repeated the eight samples again and the results were within the normal range.The customer provided the following data for 3 patients: normal range 3.4 to 20.5 umol/l on (b)(6) 2022 sid (b)(6) initial result = 165.3 umol/l, repeat result post maintenance = 14.2 umol/l, roche result = 13.3 umol/l on (b)(6) 2022 sid (b)(6) initial result = 177.4 umol/l, repeat result post maintenance = 4.6 umol/l, roche result = 3.2 umol/l on (b)(6) 2022 (b)(6) initial result = 67.3 umol/l, repeat result post maintenance = 6.4 umol/l, roche result = 5.4 umol/l no impact to patient management was reported.
|
|
Manufacturer Narrative
|
Patient identifier: sids are: (b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Manufacturer Narrative
|
The complaint investigation for falsely elevated alinity c total bilirubin results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, field data review, and labeling review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.Ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot number 60971uq11 and the complaint issue.The overall performance of the alinity c total bilirubin assay was reviewed using field data from customers worldwide.The median population result for lot 60971uq11 is within the established baseline, indicating the reagent lot is performing acceptably.Labeling was reviewed and sufficiently addresses the customer's issue.With the information provided in the complaint and this investigation, the exact cause of the shifted alinity c total bilirubin results cannot be determined.However, daily maintenance accomplishes several actions that may be a cause of shifted results.Pipettor lines are flushed removing bubbles and accumulated debris if present.The incubator water bath is exchanged along with cleaning of the pipettor probes and mixers.Each of these items are potential sources of error when results are observed to be impacted.Based on our investigation, no systemic issue or deficiency with the alinity c total bilirubin assay for lot 60971uq11 was identified.
|
|
Search Alerts/Recalls
|
|
|